NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/09/2024
Voltar para busca
Dado oficial do USPTO
C CELLPOINT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
19
Atualização mais recente
10/09/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 41, 42, 44
Data de depósito
08/02/2023
Data de registro
10/09/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/09/2024
Última transação
10/09/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
03
Localização do titular
Mechelen, BE
Examinador
BERLIN, JUSTIN
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of a red dot to the left of the letter "C" outlined in a blue and green background, to the left of the word "CELLPOINT" in stylized blue font.
Titulares e representantes
Titulares
Galapagos NV
Representantes
Alexandra MacKay STITES & HARBISON PLLC
Classificação técnica
Classes Nice
Classe 5Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical substances and preparations for human usepharmaceutical preparations and engineered patient T cells for the treatment of cancer; biopharmaceutical substances and preparations for human usebiopharmaceutical preparations and engineered patient T cells for the treatment of cancer; clinical diagnostic reagents for medical use
Classe 41
Education servicesorganizing and conducting conferencesseminarsworkshops and classes in the fields of chemistrymedicinal chemistrybiochemistrybiotechnologydrug discoverydrug development and pharmaceuticals; provision of trainingprovision of training in the fields of chemistrymedicinal chemistrybiochemistrybiotechnologydrug discoverydrug development and pharmaceuticals
Classe 42
Medicalscientific and industrial research services in the field of pharmaceuticalsengineered patient T-cellscell therapygene therapy; pharmaceutical and biopharmaceutical research and development services; laboratory analysis and testing services in the field of gene expressionanalysis and testing of cells to determine the presence of particular genes; analysis and testing of cells to determine efficacy for treatment of cancer; developmentexaminationquality controltesting of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; developmentlaboratory analysis and testing of medicaments; development of test systems in the nature of testing procedures and protocolscomputer software for testingreagents and testing kits for testing for pharmaceutical and biopharmaceutical products; development of databases in the medicalpharmaceutical and biopharmaceutical field and development of computer databanks containing information concerning gene expression and gene therapy; pharmaceutical drug development services; scientific research in the nature of conducting clinical trials for others; Providing information about the results of clinical trials for pharmaceutical products; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Classe 44
Medical services; medical and pharmaceutical advisory and consultancy services; preparing pharmaceuticals for others being engineered patient T-cells; medical servicesStemcell and celltherapy services; Medical services relating to the removaltreatment and processing of human cells
Publicações
Histórico de despachos e eventos da marca no USPTO.
19 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
10/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/06/2024
PUBO
PUBLISHED FOR OPPOSITION
25/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/06/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
16/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/02/2024
ALIE
ASSIGNED TO LIE
07/02/2024
DOCK
ASSIGNED TO EXAMINER
06/11/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/09/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
25/08/2023
GNRT
NON-FINAL ACTION E-MAILED
25/08/2023
CNRT
NON-FINAL ACTION WRITTEN
25/08/2023
DOCK
ASSIGNED TO EXAMINER
21/08/2023
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/02/2023
NWAP
NEW APPLICATION ENTERED
11/02/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace C CELLPOINT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.